Mihaela Totolici brings over 20 years of experience in pre-formulation and formulation development to drug product programs at Arcinova and Quotient Sciences. 

Mihaela joined the company in 2007 and in her current role, she oversees the design and execution of pharmaceutical development programs, ensuring a seamless transition from early-stage development to clinical batch manufacture. Her expertise spans a wide range of technologies aimed at improving the bioavailability of poorly soluble molecules as well as particle engineering strategies for inhaled drug products.

Mihaela holds a Ph.D. in Electroanalytical Chemistry from Salford University and a Bachelor of Science degree in Chemistry from Bucharest University.